# Proposed strategy after complete LAMN (low-grade appendiceal mucinous neoplasm) resection by different RENAPE units: need for a new consensus?

**Authors:** Christian Mouawad, Abdelkader Taibi, Olivia Sgarbura, Dahbia Djelil, Frédéric Marchal, Isabelle Sourrouille, Diane Goere, Olivier Glehen, Gwenael Ferron, Fréderic Dumont, Thomas Courvoisier Clement, Cécile Brigand, Koceila Lamine Amroun, Karine Abboud, Laurent Villeneuve, Marc Pocard

PMC · DOI: 10.1515/pp-2025-0037 · Pleura and Peritoneum · 2025-12-15

## TL;DR

French experts show differing post-surgery strategies for a rare appendix tumor, highlighting the need for unified guidelines.

## Contribution

Identifies significant variability in postoperative management of LAMNs among French RENAPE centers, suggesting a need for new consensus guidelines.

## Key findings

- 91% of RENAPE centers responded to the survey on postoperative strategies for LAMNs.
- Significant heterogeneity exists in follow-up recommendations, especially for intermediate-risk cases.
- Only 60% of centers recommend early CRS-HIPEC for high-risk scenarios, while others prefer laparoscopic assessment.

## Abstract

To evaluate current postoperative management strategies for incidentally discovered, completely resected low-grade appendiceal mucinous neoplasms (LAMNs) within the French RENAPE network and to assess the need for a new national consensus.

A national survey was conducted among RENAPE expert centers using a structured questionnaire based on standardized postoperative risk scenarios. Survey items addressed surveillance strategies, indications for reoperation, and use of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

Ninety-one percent of centers responded. All reported systematic multidisciplinary discussion, centralized pathology and imaging review, standardized imaging, and tumor marker assessment. Marked heterogeneity was observed. For low-risk patients (R0 resection, no perforation, no extra-appendiceal mucin), 50 % recommended no follow-up and 50 % proposed long-term MRI surveillance. In intermediate-risk cases (limited perforation or adjacent mucin), 80 % favored MRI follow-up, while 20 % recommended diagnostic laparoscopy or prophylactic CRS-HIPEC. In high-risk scenarios with radiologic suspicion of implants, 60% proposed early CRS-HIPEC, whereas others preferred laparoscopic assessment or surveillance.

This survey highlights wide variation in postoperative strategies for LAMNs within RENAPE, especially in intermediate-risk cases. While consensus exists on centralized review and imaging, significant evidence gaps persist regarding prophylactic HIPEC. These findings underscore the need for harmonized, evidence-based protocols and prospective data collection.

## Full-text entities

- **Diseases:** LAMN (MESH:D001063), mucin (MESH:D002288), perforation (MESH:D057112), tumor (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13001816/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC13001816/full.md

---
Source: https://tomesphere.com/paper/PMC13001816